Weekly News Recap #Phispers
FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations
This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...
Impressions : 4970
Headwinds at Mylan; Chinese API Adulteration Concerns Trigger Another US Drug Recall
This week in Phispers, we look at Mylan’s US operations that declined 22 percent due to lower volumes. Moreover, quality ...
Impressions : 6928
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.